Takeda Pharmaceutical (TAK) Operating Income (2017 - 2026)
Takeda Pharmaceutical's Operating Income came in at $1.26 billion for the quarter ended Jun 30, 2026, down 0.9% from $1.28 billion a year earlier and down 1.6% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Operating Income (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported Operating Income of $2.71 billion, down 43.4% year-over-year; for the year ended Mar 31, 2026, it was $41.3 million, down 98.2% from the prior year.
- Operating Income carries a five-year compound annual growth rate of -61.4% (years ended Mar 2021 to Mar 2026).
- Going back by year, Operating Income was $2.25 billion in the year ended Mar 31, 2025 (+51.5%), $1.48 billion in the year ended Mar 31, 2024 (-59.1%), $3.63 billion in the year ended Mar 31, 2023 (-11.5%) and $4.1 billion in the year ended Mar 31, 2022 (-14.6%).
- The five-year range for quarterly Operating Income is -$2.7 billion (the quarter ended Dec 31, 2025) to $2.87 billion (the quarter ended Sep 30, 2025).
- Year-over-year, Operating Income increased in five of the last six quarters, with growth averaging 5.7%.
- The fastest year-over-year change in Operating Income over five years came in the quarter ended Sep 30, 2023 (growth of 268.0%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 42.4%).
- Business Quant data shows TAK's Operating Income at $1.28 billion (quarter ended Mar 31, 2026), -$2.7 billion (quarter ended Dec 31, 2025) and $2.87 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Takeda Pharmaceutical | 2.68 Bn | -23.83 Bn | 5.10 Bn | 1.26 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | -2.70 Bn |
| Sep 30, 2025 | 2.87 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | -492.68 Mn |
| Sep 30, 2024 | 2.80 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 599.40 Mn |
| Sep 30, 2023 | 2.78 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.27 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 756.19 Mn |
| Jun 30, 2022 | 1.16 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Jun 30, 2021 | 2.27 Bn |
| Mar 31, 2021 | 2.35 Bn |
API Access
Takeda Pharmaceutical Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();